androidmj

@l_e_whyte @natalieandrews So what happens to $CAPR ?

SCOOP- A frustrated President Trump upbraided FDA Commissioner Marty Makary this weekend for not moving quickly enough to approve flavored vapes and nicotine products. Makary is on thin ice. with @natalieandrews gift link below

@pilky0001 @Stonkfather2021 @stoolpresidente @CGilligan24 He knows the answer. Issue more shares and debt. He just didn’t want to say it. You think he doesn’t know after putting up a $56B bid?? Come on.

@Stonkfather2021 @stoolpresidente @CGilligan24 They asked them a basic question about where the financing would come from and he had no answer. Embarrassing.

I’ve had my best people at #ddtg pour over this video and I’m still not sure who won this exchange.

@WSJ @WSJopinion Hire Hemmati asap.

From @WSJopinion: Trump has a Marty Makary problem. Bad decisions and lots of drama make the FDA commissioner a headache for the president, writes Allysia Finley. on.wsj.com/4u7CYcB

@elation0x @HighyieldHarry You’re wrong. He’s just annoyed

@HighyieldHarry Dude’s clearly in over his head

ahhhhh I'm Ryan Cohen and I'm on CNBC and the journalists are asking me questions while I'm on CNBC ahhhhhh

@DrToonces Deramiocel too $CAPR

Drugs the WSJ Editorial Board has called out the FDA for blocking under Makary in the past nine months: Replimune RP1 (metastatic melanoma) AMT-130 (Huntington's disease) RGX-121 (Hunter syndrome) Bitopertin (EPP) Moderna mRNA flu vaccine Five drugs. Five rejections. One commissioner. One editorial board paying attention. wsj.com/opinion/presid… $QURE #AMT130

@WSJopinion Hemmati should be his replacement

Trump has a Marty Makary problem. Bad decisions and lots of drama make the FDA commissioner a headache for the president, writes Allysia Finley on.wsj.com/3QOA0e3

Spot on @Elijahjstacy - patients deserve simple clarity on the FDA’s true role. FDA approval is not an endorsement that a drug is “incredible” or the best on the market. It’s like a building permit: it simply confirms the therapy meets rigorous standards for safety and efficacy. Once that permit is granted & the drug reaches the market, FDA is only one of four layers of protection & decision-making. Patients can choose not to take it, doctors can decide not to prescribe it, and insurers can opt not to pay if it’s not right for that individual. Taking away choice because a drug isn’t “absolutely perfect” means patients and physicians never even get the option to consider it. Putting patients first means preserving every possible tool—so families and doctors can decide together.

This is a NO BRAINER that should have been done a long time ago. No more sticker shock at the pharmacy. No more walking away after waiting in line because of a massive copay or no insurance coverage, then begging doc for a different prescription. This empowers Americans.

@RxRegA Well just because he supported your view on this vaccine doesn’t mean he was a good director. He very clearly single handedly denied many new therapies including Capricor’s deramiocel.

Unfortunately, another senior official well-poised to handle vaccines differently, CBER Director Dr. Vinay Prasad, is leaving the FDA this month. Prasad pushed a more cautious approach — overriding staff to narrow broad COVID vaccine approvals and flagging VAERS signals of potential harm — before his departure.

It must be incredibly difficult to be a veteran FDA scientific expert with decades of experience, working on analyses that flag potential safety signals, only to be directed to “cease and desist” that work while CBER leadership internally described it as a “major distraction” over concerns it could feed anti-vaccination rhetoric. What could be more important than rigorously investigating those signals? (Attaching the email that prompted this reflection)

Just attended an amazing panel by senior @FDA & @NIH leadership at @Stanford - including presentations by @FDACDERDirector Director of CDRH, Deputy CBER Director, Chief Scientist & NIH Deputy Director, who outlined their patient-focused plans to improve Americans’ health through efficient, quality science. It’s an exciting time!

@US_FDA @DrMakaryFDA And announce a new cber director???? What’s the hold up?

At 1:30pm today, FDA Commissioner @DrMakaryFDA will unveil FDA's real-time clinical trials initiative—a major step to accelerate cures for patients. Join us! youtube.com/live/hPT6X4SKO…

JOSH ALLEN WITH THE GREATEST DRUM OF ALL TIME‼️ #LetsGoBuffalo | @BuffaloBills

@bronxb_13 @BullLogic When

@BullLogic Cber director announcement incoming

$capr heading to 40

Major problem

@r0ck3t23 Well where is the Tesla roadster??? Elon has never been good at time prediction.

Elon Musk just told the world to stop training surgeons. Not slow down. Stop. Musk: “There’ll probably be more Optimus robots that are great surgeons than there are all surgeons on Earth.” The entire global surgical workforce. Redundant. Before a current med student finishes residency. “Don’t go to medical school?” Musk: “Yes. Pointless.” Twelve years. Half a million dollars. One word. Optimus does not shake. Does not fatigue. Does not flinch at hour eleven of a twelve-hour operation. It improves every night while the surgeon sleeps. By year four, Musk says he’d stake everything on it. By year five, it is not close. Then came the line that rewrites who medicine has ever belonged to. Musk: “Everyone will have access to medical care that is better than what the president receives right now.” Medicine has always been rationed by wealth. The best surgeons on Earth have always belonged to the powerful. That ends. Completely. Within five years. The machine does not calibrate its precision to your net worth. It does not save its best work for the wealthy. Full capacity, every time, for everyone. One day, choosing a human surgeon over a robot will feel like refusing the anesthesia. Human hands are no longer medicine’s highest standard. The ones who doubted this will understand it the day they need surgery, not a surgeon.

@Azkyrie @PeterSchiff @Kontora wtf are you smoking? $17T??? Ok

@PeterSchiff @Kontora Trump pulls in $17Trillion for the U.S. in trade deals. SCOTUS only ruled one measure of tariffs couldn’t be used. Which is why Trump legally raised tariffs immediately afterwards

Trump used Truth Social to dramatically escalate the war on Saturday, only to do a complete 180 just before the stock market opened on Monday. Is this Trump being a master negotiator, market manipulation, or just an indication that the President has no idea what he is doing?

HOW IS THIS NORMAL? Trump on the girls’ school in Minab: “The Tomahawk missile that destroyed it could have been anyone’s. A Tomahawk is very generic.” Facts: Tomahawk missiles are manufactured by RTX in Phoenix, Arizona. The US sells them to exactly four countries: the UK, Australia, Japan, and the Netherlands. None of them are at war with Iran. The White House already confirmed behind closed doors to Congress that the US targeted the area. CNN confirmed US responsibility. 165 girls aged 7-12 are dead. And the President of the United States just told the American people a Tomahawk missile is “very generic.” This is not a mistake. This is not confusion. This is a lie. On camera. About dead children.

Connor McGovern: "$13 milllion is a whole hell of a lot of money. If me and my family can't live off that, shame on us...is a couple million dollars worth our happiness here? Is that going to change our lives? We decided 'no' and we thought the best fit would be here inBuffalo."

Donald Trump: "We don't want to get into wars." "I'm the only president in the last 84 years that didn't start a war." "We will have no more wars." "We will have prosperity and peace." "Remember, I'm the president of peace." "I'm not going to start a war. I'm going to stop wars."

A year ago we were supposed to be getting $2,000 rebate checks, DOGE was going to find $2 trillion in waste to balance the budget, we were going to pay no income taxes because tariffs would pay for everything, gas & home electric bills would be cut in half, and no new wars.